Domine Gomez M, Csoszi T, Jaal J, Kudaba I, et al. Exploratory composite endpoint demonstrates benefit of trilaciclib across multiple clinically meaningful components of myeloprotection in patients with small cell lung cancer. Int J Cancer 2021 Jun 10. doi: 10.1002/ijc.33705.
PMID: 34109630